| |
| |
|
| Insider
Information: |
Luo Mary Z. |
| Relationship: |
COO,Chief Scientist & ... |
| City: |
Rancho Cucamonga |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
2,433,554 |
|
|
Indirect Shares
|
8,057,435 |
|
|
| Direct
Value |
$102,744,650 |
|
|
|
Indirect Value
|
$340,184,906 |
|
|
| Total
Shares |
10,490,989 |
|
|
| Total
Value |
$442,929,556 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amphastar Pharmaceuticals, Inc. |
AMPH |
COO,Chief Scientist & ... |
2024-03-17 |
2,433,554 |
2024-03-17 |
8,057,435 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
• • • |
2015-12-08 |
4 |
AS |
$14.50 |
$353,118 |
I/I |
(24,359) |
7,524,894 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
• • • |
2015-12-09 |
4 |
AS |
$14.29 |
$376,133 |
I/I |
(26,319) |
7,498,575 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
• • • |
2015-12-10 |
4 |
AS |
$14.32 |
$313,884 |
I/I |
(21,915) |
7,476,660 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
• • • |
2015-12-11 |
4 |
AS |
$14.05 |
$211,736 |
I/I |
(15,066) |
7,461,594 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • – |
2016-03-17 |
4 |
A |
$0.00 |
$0 |
I/I |
79,435 |
767,666 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • – |
2016-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
184,466 |
1,129,902 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2016-03-26 |
4 |
D |
$11.96 |
$80,180 |
I/I |
(6,704) |
760,962 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2016-03-26 |
4 |
D |
$11.96 |
$187,904 |
D/D |
(15,711) |
1,114,191 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2016-03-27 |
4 |
D |
$11.96 |
$309,238 |
D/D |
(25,856) |
1,088,335 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2016-03-27 |
4 |
D |
$11.96 |
$103,346 |
I/I |
(8,641) |
752,321 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
• • • |
2016-09-20 |
4 |
AS |
$20.74 |
$3,825,732 |
I/I |
(181,768) |
752,321 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
• • • |
2016-09-20 |
4 |
OE |
$16.75 |
$3,045,159 |
I/I |
181,768 |
934,089 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
• • • |
2016-09-20 |
4 |
AS |
$20.73 |
$4,376,738 |
D/D |
(207,350) |
1,088,335 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
• • • |
2016-09-20 |
4 |
OE |
$16.75 |
$3,473,735 |
D/D |
207,350 |
1,295,685 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
• • • |
2016-09-21 |
4 |
AS |
$20.70 |
$1,140,334 |
D/D |
(55,081) |
1,088,335 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
• • • |
2016-09-21 |
4 |
OE |
$16.75 |
$922,772 |
D/D |
55,081 |
1,143,416 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2017-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
156,554 |
1,244,889 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2017-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
67,415 |
819,736 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2017-03-17 |
4 |
D |
$13.75 |
$317,735 |
D/D |
(23,108) |
1,221,781 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2017-03-17 |
4 |
D |
$13.75 |
$136,826 |
I/I |
(9,951) |
809,785 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist Chairman |
• • • |
2017-03-26 |
4 |
D |
$13.76 |
$92,247 |
I/I |
(6,704) |
803,081 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist Chairman |
• • • |
2017-03-26 |
4 |
D |
$13.76 |
$299,954 |
D/D |
(21,799) |
1,199,982 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist Chairman |
• • • |
2017-03-27 |
4 |
D |
$14.27 |
$392,140 |
D/D |
(27,480) |
1,172,502 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist Chairman |
• • • |
2017-03-27 |
4 |
D |
$14.27 |
$132,297 |
I/I |
(9,271) |
793,810 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2017-05-23 |
4 |
OE |
$11.51 |
$3,047,882 |
I/I |
264,895 |
1,058,705 |
0 |
- |
|
170 Records found
|
|
Page 3 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
